NCT03333343 2026-01-16Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCNovartisPhase 1 Active not recruiting105 enrolled
NCT04294160 2025-12-24A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal CancerNovartisPhase 1 Terminated122 enrolled